Investment

Deal of the Week: One of America’s wealthiest families backs transformative healthcare group

In a world subsumed by the coronavirus, biotech and healthcare companies seem completely irrelevant right now. But that hasn’t stopped a big investment by one of America’s wealthiest families in what is proving to be a transformative healthcare company. 

Koch Disruptive Technologies – the venture group owned by Chase Koch, the son of multi-billionaire Charles Koch – has invested in InSightec. The Israel-based healthcare group makes magnetic-resonance-guided ultrasound technology devices for image-guided acoustic surgery. InSightec has developed transformative technology, which makes it possible to perform completely non-invasive surgery on the brain and other parts of the body. 

As InSightec says on its website: “the surgeon is equipped with a workstation, keyboard and mouse – no scalpel in sight”

Koch Disruptive invested $150 million of growth capital in InSightec after backing them in an earlier funding round. 

InSightec has so far raised nearly $500 million in capital – so its valuation is definitely in unicorn territory. 

Koch Disruptive is certainly splashing the case around since it was founded in late 2017. Last month, it led a Series B round worth $30 million in cloud-based security group Automox. Other investments have included Ibotta, an application that pays its users for shopping online or in-store, Desktop Metals, a 3D print metal parts company, and D2iQ, a cloud-based infrastructure group.

Subscribe

You will need a Premium Plus Subscription to access this database.

Exclusive news, analysis and research on global family enterprise and private investment offices.

Access to the most comprehensive fully interactive database on global family offices, principal investment offices, and family enterprises.

Check Deal Data, Senior Staff, and New Analysis on more than 500 family/principal investment and holding groups

Already have an account? Login

Subscribe

You need at least a Premium Subscription to read this article.

The most comprehensive information service on the global family enterprise world, featuring exclusive news, analysis, research and data on global family enterprises, family offices, and private investment offices.

Premium

£299

per year

  • Exclusive reports, analysis and commentary
  • Exclusive access to family/private investment office deal information
  • Exclusive interviews with principals and senior management of family/investment offices
SUBSCRIBE NOW

Premium+

£399

per year

  • Access to All of Premium
  • Access to all of FamilyCapital Analytics, our interactive database with more than 500 detailed profiles of family investment groups

More Info

SUBSCRIBE NOW

Already have an account? Login

You've reached the end.

Continue reading free articles by registering as a Member.
Or choose a Premium Plan.

Membership

Free

  • Exclusive reports, analysis and commentary
REGISTER NOW

Premium

£299

per year

  • Exclusive reports, analysis and commentary
  • Exclusive access to family/private investment office deal information
  • Exclusive interviews with principals and senior management of family/investment offices
SUBSCRIBE NOW

Premium+

£399

per year

  • Access to All of Premium
  • Access to all of FamilyCapital Analytics, our interactive database with more than 500 detailed profiles of family investment groups

More Info

SUBSCRIBE NOW

Already have an account? Login

Leave a Reply